|
2008 Journal Article Central blood pressure measurement may improve risk stratificationSharman, J.E., Stowasser, M., Fassett, R.G., Marwick, T.H. and Franklin, S.S. (2008). Central blood pressure measurement may improve risk stratification. Journal of Human Hypertension, 22 (12), 838-844. doi: 10.1038/jhh.2008.71 |
|
2008 Journal Article Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflamation in renal transplant patients (Xanthin): A randomised controlled trialFassett, Robert G., Driver, Ritza, Healy, Helen, Robertson, Iain K., Geraghty, Dominic P., Sharman, James E. and Coombes, Jeff S. (2008). Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflamation in renal transplant patients (Xanthin): A randomised controlled trial. BMC Nephrology, 9 (1) 17, 17.1-17.8. doi: 10.1186/1471-2369-9-17 |
|
2008 Journal Article Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trialJohnson, David Wayne, Hawley, Carmel Mary, Rosser, Brenda, Beller, Elaine, Thompson, Charles, Fassett, Robert G., Ferrari, Paolo, MacDonald, Stephen, Pedagogos, Eugenie and Cass, Alan (2008). Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial. BMC Nephrology, 9 (1) 8, 8-1-8-7. doi: 10.1186/1471-2369-9-8 |
|
2008 Journal Article Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protectionBulmer, Andrew C., Blanchfield, Joanne T., Toth, Istvan, Fassett, Robert G. and Coombes, Jeff S. (2008). Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection. Atherosclerosis, 199 (2), 390-396. doi: 10.1016/j.atherosclerosis.2007.11.022 |
|
2008 Journal Article The Lipid lowering and Onset of Renal Disease (LORD) trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progress of kidney diseaseFassett, Robert G., Ball, Madeleine J., Robertson, Iain K., Geraghty, Dominic P. and Coombes, Jeff S. (2008). The Lipid lowering and Onset of Renal Disease (LORD) trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progress of kidney disease. BMC Nephrology, 9 (1) 4, 4.1-4.6. doi: 10.1186/1471-2369-9-4 |
|
2008 Journal Article Laparoscopic gastric banding surgery performed in obese dialysis patients prior to kidney transplantationKoshy, A.N., Coombes, J.S., Wilkinson, S. and Fassett, R.G. (2008). Laparoscopic gastric banding surgery performed in obese dialysis patients prior to kidney transplantation. American Journal of Kidney Diseases, 52 (4), e15-e17. doi: 10.1053/j.ajkd.2008.05.016 |
|
2007 Journal Article A national survey of medical morning handover report in Australian hospitals - ReplyFassett, Matthew J., Hannan, Terry J., Robertson, Iain K., Bollipo, Steven J. and Fassett, Robert G. (2007). A national survey of medical morning handover report in Australian hospitals - Reply. Medical Journal of Australia, 187 (10), 595-596. doi: 10.5694/j.1326-5377.2007.tb01430.x |
|
2007 Journal Article A national survey of medical morning handover report in Australian hospitalsFassett, Matthew J., Hannan, Terry J., Robertson, Iain K., Bollipo, Steven J. and Fassett, Robert G. (2007). A national survey of medical morning handover report in Australian hospitals. Medical Journal of Australia, 187 (3), 164-165. doi: 10.5694/j.1326-5377.2007.tb01176.x |
|
2007 Journal Article Simvastatin-Induced rhabdomyolysis following cyclosporine treatment for uveitisLasocki, Anita, Vote, Brendan, Fassett, Robert and Zamir, Ehud (2007). Simvastatin-Induced rhabdomyolysis following cyclosporine treatment for uveitis. Ocular Immunology and Inflammation, 15 (4), 345-346. doi: 10.1080/09273940701375147 |
|
2007 Journal Article Dietary intake of patients with chronic kidney disease entering the LORD trial: Adjusting for underreportingFassett, R. G., Robertson, I. K., Geraghty, D. P., Ball, M. J. and Coombes, J. S. (2007). Dietary intake of patients with chronic kidney disease entering the LORD trial: Adjusting for underreporting. Journal of Renal Nutrition, 17 (4), 235-242. doi: 10.1053/j.jrn.2007.04.004 |
|
2007 Journal Article Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) TrialSummers, M. J., Oliver, K. R., Coombes, J. S. and Fassett, R. G. (2007). Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) Trial. Pharmacotherapy, 27 (2), 183-190. doi: 10.1592/phco.27.2.183 |
|
2007 Journal Article Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndromeShaw, Elizabeth A., Colville, Deb, Wang, Yan Yan, Zhang, Ke Wei, Dagher, Hayat, Fassett, Rob, Guymer, Robyn and Savige, Judy (2007). Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Nephrology Dialysis Transplantation, 22 (1), 104-108. doi: 10.1093/ndt/gfl607 |
|
2006 Journal Article Morning report: an Australian experienceFassett, Robert G. and Bollipo, Steven J. (2006). Morning report: an Australian experience. Medical Journal of Australia, 184 (4), 159-161. |
|
2006 Journal Article Baseline serum lipids and renal function in chronic kidney disease patients entering the LORD trialFassett, RG, Ball, MJ, Robertson, I.K., Geraghty, D.P. and Coombes, J.S. (2006). Baseline serum lipids and renal function in chronic kidney disease patients entering the LORD trial. International Journal of Clinical Pharmacology And Therapeutics, 44 (11), 580-588. doi: 10.5414/CPP44580 |
|
2006 Journal Article alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated ratsLexis, L. A., Fassett, R. G. and Coombes, J. S. (2006). alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats. Basic & Clinical Pharmacology & Toxicology, 98 (1), 68-73. doi: 10.1111/j.1742-7843.2006.pto_222.x |
|
2006 Journal Article Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipientsAusten, S.K., Fassett, R.G., Geraghty, D.P. and Coombes, J.S. (2006). Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients. Clinical Nephrology, 66 (5), 373-379. doi: 10.5414/cnp66373 |
|
2006 Journal Article Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunctionLexis, L. A., Fenning, A., Brown, L., Fassett, R. G. and Coombes, J. S. (2006). Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction. American Journal of Transplantation, 6 (1), 41-49. doi: 10.1111/j.1600-6143.2005.01154.x |
|
2005 Journal Article Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trialKeech, A., Simes, R. J., Barter, P., Best, J., Scott, R., Taskinen, M. R., Forder, P., Pillai, A., Davis, T., Glasziou, P., Drury, P., Kesaniemi, Y. A., Sullivan, D., Hunt, D., Colman, P., D'Emden, M., Whiting, M., Ehnholm, C., Laakso, M., Beller, E., FIELD Study Investigators and Fassett, Robert (2005). Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. The Lancet, 366 (9500), 1849-1861. doi: 10.1016/S0140-6736(05)67667-2 |
|
2005 Journal Article No relationship between low-density lipoproteins and endothelial function in hemodialysis patientsDalton, B. S., Fassett, R. G., Geraghty, D. P., De Ryke, R. and Coombes, J. S. (2005). No relationship between low-density lipoproteins and endothelial function in hemodialysis patients. International Journal of Cardiology, 99 (2), 307-314. doi: 10.1016/j.ijcard.2004.02.004 |
|
2005 Journal Article Acute exposure to cyclosporine does not increase plasma homocysteine in ratsAusten, S. K., Fletcher, L. A., Fassett, R. G., Booth, C. and Coombes, J. S. (2005). Acute exposure to cyclosporine does not increase plasma homocysteine in rats. Transplantation Proceedings, 37 (10), 4543-4546. doi: 10.1016/j.transproceed.2005.11.012 |
